Locate your nearest distributor

Text search:
Forgot password?


Dysbiosis test

Recently, there has been a growing interest within the medical and scientific community towards a condition known as dysbiosis, which can be described as a microbial imbalance within the body. 

As an example, dysbiosis of the gut flora has been linked in several scientific publications to contribute to various medical conditions such as Inflammatory Bowel Disease  (IBD) {ulcerative colitis (UC), Crohn’s disease (CD)}, Irritable Bowel Syndrome (IBS), obesity, nonalcoholic steatohepatitis, and type I and type II diabetes. 

Traditionally, the identification of dysbiosis has been based on breath-testing methods and small-bowel culture techniques, which are not well validated and do not give a thorough picture of the gut microbiota. 

To overcome these challenges, Biohit, together with Norwegian company Genetic Analysis AS, has introduced the GA-map Dysbiosis test, which is the first CE marked gut microbiota DNA analysis tool to identify and characterize dysbiosis from a fecal sample. This test provides a rapid, high-throughput analysis of a large number of individual faecal samples.